MILFORD, Mass., Sept. 29, 2011 /PRNewswire/ --Waters Corporation (NYSE: WAT) today introduced TruView™ LCMS Certified Vials, a new line of low-adsorption sample vials certified for LC/MS/MS analyses ...

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) today introduced the BioAccord™ System, a purposefully designed liquid chromatography-mass spectrometry (LC-MS) solution that will expand ...

Waters Corp.WAT recently announced that its indigenously built ACQUITY UPLC I-Class IVD/Xevo TQ-S micro IVD System has been classified as a U.S. FDA Class I medical device. Moreover, it has secured ...

Waters Corporation WAT has been continuously making new enhancements to gain momentum in the Liquid Chromatography Mass Spectrometry (LC-MS) market. This is evident from the fact that the company ...

Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs ...

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE: WAT) today announced that the Waters ® ACQUITY UPLC ® I-Class IVD/Xevo ® TQ-S micro IVD System is now manufactured as a U.S. FDA Class I ...

On Tuesday, Jefferies elevated its position on Waters Corporation (NYSE:WAT) stock, a prominent analytical instrument manufacturer, from Hold to Buy. The firm also increased its price target for the ...

MILFORD, Mass., Oct. 10, 2024 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today introduced a comprehensive set of sample preparation enzymes, reagents, and waters_connect software that simplify ...

Waters Corporation has introduced TruView™ LCMS Certified Vials, a new line of low-adsorption sample vials certified for LC/MS/MS analyses where analyte concentrations are on the order of ng/mL or ...